From Japan's Kobayashi Pharmaceutical's red yeast rice supplement scandal to Unilever's hydration brand Liquid I.V. making its way into more markets, including China and Australia, here are the most-read stories on NutraIngredients-Asia...
A new formula combining vitamin K2 and red yeast rice extract from SunWay Biotech and Gnosis by Lesaffre is being pitched as ‘pivotal chance’ to boost cardiometabolic health in Asia.
Japan’s Consumer Affairs Agency (CAA), which oversees the Foods with Function Claims (FFC) sector, is asking all businesses to declare any health hazards linked to their products in the wake of Kobayashi Pharmaceutical’s red yeast rice saga.
Red yeast rice extract production would need to fulfill three key elements of testing to ensure product safety, industry experts highlighted amid an ongoing crisis involving products made using Japan’s Kobayashi Pharmaceutical's red yeast rice raw...
Japan’s Kobayashi Pharmaceutical is halting the production of all its red yeast rice raw material and supplements containing the raw material, following consumer complaints of kidney disease. The company is also recalling all of its products that contain...
Taiwan-based health food manufacturer Daiken Biomedical believes that patent grants are the “most secure and safe guarantee” to gain consumer trust, and could play a major role in driving business expansion.
The Taiwan Food and Drug Administration is proposing warning statements to be printed on health foods containing fish oil and red yeast rice due to their potential interaction with certain medications.
